1. Web alert

   OriginalPaper 29 August 2007 Pages: 341 - 341

2. The COURAGE trial: Establishing the Therapeutic Legitimacy of Aggressive Risk Factor Management in Patients with Stable Coronary Artery Disease as an Alternative to Percutaneous Coronary Intervention

   • Peter P. Toth

   Clinical Trials Report 29 August 2007 Pages: 345 - 346

3. SPARCL: The glimmer of statins for stroke risk reduction

   • Annemarie Armani
   • Peter P. Toth

   OriginalPaper 29 August 2007 Pages: 347 - 351

4. Does it matter how you lower blood pressure in patients with uncomplicated hypertension? Weighing the evidence

   • Daniel A. Duprez

   OriginalPaper 29 August 2007 Pages: 352 - 358

5. Rimonabant: The role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients

   • Christopher T. Dibble
   • Eli V. Gelfand
   • Christopher P. Cannon

   OriginalPaper 29 August 2007 Pages: 359 - 366

6. Dyslipidemia in South Asian patients

   • Enas A. Enas
   • Vinod Chacko
   • Heyer Paul Devarapalli

   OriginalPaper 29 August 2007 Pages: 367 - 374

7. Should hyperhomocysteinemia be treated in patients with atherosclerotic disease?

   • Bradley A. Maron
   • Joseph Loscalzo

   OriginalPaper 29 August 2007 Pages: 375 - 383

8. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?

   • James K. Liao

   OriginalPaper 29 August 2007 Pages: 384 - 388

9. Statin myopathy: Incidence, risk factors, and pathophysiology

   • Kimberly A. Sewright
   • Priscilla M. Clarkson
   • Paul D. Thompson

   OriginalPaper 29 August 2007 Pages: 389 - 396

10. Evidence-based treatment of unprotected left main disease: A critical review of the literature

    • Peter Sharis
    • Nicolas W. Shammas

    OriginalPaper 29 August 2007 Pages: 397 - 400

11. Clopidogrel and risk for acute coronary events

    • Girish R. Mood
    • Deepak L. Bhatt

    OriginalPaper 29 August 2007 Pages: 401 - 408

12. Aspirin in the treatment and prevention of cardiovascular disease: Current perspectives and future directions

    • Charles H. Hennekens

    OriginalPaper 29 August 2007 Pages: 409 - 416

13. Myeloperoxidase and inflammatory proteins: Pathways for generating dysfunctional high-density lipoprotein in humans

    • Tomáš Vaisar
    • Baohai Shao
    • Jay W. Heinecke

    OriginalPaper 29 August 2007 Pages: 417 - 424